Skip to main content

Table 1 Clinical and laboratory characteristics of the study population

From: The significance of fibroblast growth factor-2 and kidney injury molecule-1 as biomarker of interstitial renal fibrosis in glomerulonephritis

Eighty non-diabetic patients with glomerulonephritis

Count

%

Sex

Female

39

48.8%

Male

41

51.2%

HTN

Yes

42

52.5%

No

38

47.5%

Albumin in urine

Nil

2

2.5%

+

2

2.5%

++

15

18.8%

+++

59

73.8%

++++

2

2.5%

HBs Ag

Positive

4

5.0%

Negative

76

95.0%

HCV Ab

Positive

6

7.5%

Negative

74

92.5%

HIV

Positive

0

0.0%

Negative

80

100.0%

ANA

Positive

27

33.8%

Negative

53

66.3%

ADNA

Positive

27

33.8%

Negative

53

66.3%

C3

Consumed

31

38.8%

Normal

49

61.3%

C4

Consumed

25

31.3%

Normal

55

68.8%

Degree of fibrosis

No

20

25.0%

Mild

15

18.8%

Moderate

23

28.7%

Severe

22

27.5%

GFR

Stage 1

22

27.5%

Stage 2

14

17.5%

Stage 3A

17

21.3%

Stage 3B

27

33.8%